- New 3D imaging capabilities of Sonic DL are designed to enable
up to 86%i faster scans and enhanced resolution for brain, spine,
orthopedic and body imaging.
- Combination of Sonic DL and AIR Recon DL accelerates workflow
while improving diagnostic confidence and patient comfort.
GE HealthCare (Nasdaq: GEHC) today unveiled Sonic DL for 3Dii,
the newest addition to its effortless imaging portfolio, designed
to accelerate MRI scans across a wide range of clinical
applications. Sonic DL for 3D builds on GE HealthCare’s deep
learning innovation legacy and the success of AIR Recon DL, which
has helped over 34 million patients to date. Initially launched in
2023 for Cardiac MRI, Sonic DL provides up to 12 times scan
acceleration while maintaining diagnostic qualityiii. Now, GE
HealthCare is extending Sonic DL to 3D volumetric imaging,
designing it to broaden its applicability to brain, spine,
orthopedic and body exams, in addition to cardiac. This expansion
is intended to retain the same impressive 12x acceleration and
reduce scan times by up to 86%.
Healthcare burnout has reached critical levels, with 63% of
physicians and 49% of nurses reporting symptoms of burnout,
according to a 2023 American Medical Association (AMA) surveyiv.
Rising workloads, time constraints, and staffing shortages
contribute to high stress and fatigue among healthcare
professionals, directly impacting patient care. Addressing these
challenges, Sonic DL for 3D is designed to help enable faster,
high-quality imaging for a majorityv of MR exams. By combining
Sonic DL’s speed with AIR Recon DL’svi noise reduction technology,
this deep learning integration is intended to empower clinicians to
significantly cut scan times, enhance image resolution by up to
55%, and enable faster, accurate diagnoses with greater ease.
In neurology, Sonic DL 3D is designed to enable high-resolution
imaging of complex brain structures, allowing for quicker, clearer
insights into neurological conditions. In orthopedics, it will help
to speed up the imaging of joints, ligaments, and bones, reducing
scan times to minimize patient discomfort, especially for those
with mobility challenges. By advancing speed and clarity in these
critical areas, Sonic DL 3D helps to enhance clinical workflows,
improve patient comfort, and support timely diagnoses.
“Today’s unveiling of Sonic DL for 3D reinforces our commitment
to advancing medical imaging,” said Kelly Londy, President &
CEO, Global MR, GE HealthCare. “Our deep learning, effortless
imaging portfolio has already seen great success with AIR Recon DL
and Sonic DL for cardiac. Now, with Sonic DL’s expansion to 3D and
its ability to combine with AIR Recon DL, we’re offering a
combination of speed, accuracy, and clarity. We believe Sonic DL
will be a game-changer in key clinical areas, substantially
impacting our customers' ability to deliver high-quality care while
enhancing the capabilities of their existing systems through
seamless upgrades.”
GE HealthCare’s ongoing investment in deep learning
technologies, available for both in-field MR upgrades and new
installations, supports its vision of sustainable and equitable MR
access. By equipping facilities with faster, high-quality imaging
solutions, GE HealthCare aims to help healthcare providers reduce
patient backlogs, increase exam capacity, and deliver more
cost-effective care.
With Sonic DL’s extended capabilities in 3D imaging, GE
HealthCare continues to lead as a top provider of AI-integrated MR
technology, supporting clinicians in delivering precise, timely
diagnostics while enhancing the patient experiencevii.
Learn more about Sonic DL 3D at the Radiological Society of
North America (RSNA) Annual Meeting, December 1–4, 2024, in
Chicago, or online at gehealthcare.com.
About GE HealthCare Technologies Inc.
GE HealthCare is a leading global medical technology,
pharmaceutical diagnostics, and digital solutions innovator,
dedicated to providing integrated solutions, services, and data
analytics to make hospitals more efficient, clinicians more
effective, therapies more precise, and patients healthier and
happier. Serving patients and providers for more than 125 years, GE
HealthCare is advancing personalized, connected, and compassionate
care, while simplifying the patient’s journey across the care
pathway. Together our Imaging, Advanced Visualization Solutions,
Patient Care Solutions, and Pharmaceutical Diagnostics businesses
help improve patient care from diagnosis, to therapy, to
monitoring. We are a $19.6 billion business with approximately
51,000 colleagues working to create a world where healthcare has no
limits.
Follow us on LinkedIn, X, Facebook, Instagram, and Insights for
the latest news, or visit our website https://www.gehealthcare.com
for more information.
i
Internal Data on file; Product
Data Sheet Reference DOC3050862
ii
Sonic DL for 3D is 510(k) pending
at the US FDA. Not yet CE Marked. Not available for sale in all
regions.
iii
GE HealthCare data on file
iv
http://www.ama-assn.org/practice-management/physician-health/5-things-health-care-organizations-learned-about-burnout-year
v
Data on File, REF-06122
vi
https://www.gehealthcare.com/about/newsroom/press-releases/ge-healthcares-air-recon-dl-receives-fda-clearance-of-3d-and-motion-insensitive?npclid=botnpclid&srsltid=AfmBOoofhQrkegrnQapO24VI5GFj9NGha52mArf78AKq6kw5w_vG22fR
vii
https://www.gehealthcare.com/about/newsroom/press-releases/ge-healthcare-tops-list-for-third-year-in-a-row-with-highest-number-of-ai-enabled-medical-device-authorizations
View source
version on businesswire.com: https://www.businesswire.com/news/home/20241201889293/en/
GE HealthCare Media Contact: Kimberly Schmohl M +1 929
289 1937 kimberly.schmohl@gehealthcare.com
GE HealthCare Technologies (NASDAQ:GEHC)
Historical Stock Chart
From Dec 2024 to Jan 2025
GE HealthCare Technologies (NASDAQ:GEHC)
Historical Stock Chart
From Jan 2024 to Jan 2025